Magnetic stimulation of the brain increase Na + , K + -ATPase activity decreased by injection of ALCL 3 into nucleus basalis magnocellularis of rats

International Journal of Neuroscience

Volumn 116, Issue 6, 2006, Pages 681-695

  Jovanova Nesic, Katica ^a,c   Eric Jovicic, Milena ^a   Spector, Novera ^b  

^a Immunology Research Center Belgrade   (Yugoslavia)

^b NIM Institute   (Serbia)

^c Biomedical Center Institute Torlak   (Serbia)

Author keywords

AlCl 3; Erythrocyte membranes; K ATPase; Na; Nucleus basalis magnocellularis; Rat; Stationary magnetic fields

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALUMINUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD; BRAIN DAMAGE; BRAIN FUNCTION; BRAIN REGION; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE MEMBRANE; MAGNET; MAGNETIC STIMULATION; MAGNOCELLULAR NUCLEUS; NONHUMAN; OLIVARY NUCLEUS; PINEAL BODY; PROTEIN CONTENT; RAT; SKULL; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE;

EID: 33745064173     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.1080/00207450600674830     Document Type: Article

References (69)

1. Alagone, G., Bella, R., Fern, R., Carnemollo, A., Pappolardo, A., Constanzo, E. M., & Pennisi, G. (2001). Transcranial magnetic stimulation in Alzheimer's disease: Motor cortex excitability and cognitive severity. Neuroscience Lett., 314(1-2), 57-60.
2. Arendash, G. W., Millard, W. J., Dunn, A. J., & Meyer, E. M. (1987). Long-term neuropathological and neurochemical effects of nucleus basalis lesions in the rat. Science, 238, 952-956.
3. Ashner, M., & Allen, J. W. (2001). Mercuric chloride, but not methyl mercury, inhibits glutamine synthesise activity in primary cultures of cortical astrocytes. Brain Res., 891(1-2), 148-57.
4. Bardasano, J. C. (1989). The pineal gland and magnetic fields. Universidad de Alacala de Menares, Madrid.
5. + transport through human erythrocyte membranes. Studia Universitatis Babes. Boliat, Physica, Special issue.
6. Blank, M., & Goodman, R. (2004). Initial interactions in electromagnetic fields-induced biosynthesis. Journal of Cellular Physiology, 199, 359-364.
7. Blank, M., & Soo, L. (2001). Optimal frequencies for magnetic acceleration of cytochrome oxidase and Na,K-ATPase reactions. Bioelectrochemistry and Bioenergetics, 53(2), 171-174.
8. Brown, F. A. (1969). A hypothesis for extrinsic timing of circadian rhythm. Canadian Journal of Biology, 47, 287-298.
9. Cauhan, N. B., Lee, J. M., & Siegel, G. J. (1997). Na,K-ATPase mRNA level and plaque load in Alzheimer's disease. J. Mol. Neurosci., 9(3), 151-166.
10. Coyle, J. T., Price, D. L., & DeLong, R. (1983). Alzheimer's disease: A disorder of cortical cholinergic innervations. Science, 219, 1184-1190.
11. Davidson, M., Bastiaens, L., Davis, B. M., Shah, M. B., & Davis, K. L. (1988). Endocrine changes in Alzheimer's disease. Neurologic Clinics, 6, 147-157.
12. de Carvalho, M., de Mendonca, A., Miranda, P. C., Garcia, C., & Luis, M. L. (1997). Magnetic stimulation in Alzheimer's disease. J. Neurol., 244(5), 304-307.
13. de la Torre, J. C. (1997). Homodynamic consequences of deformed microvessels in the brain in Alzheimer's disease. Ann. N.Y. Acad. Sc., 826, 75-91.
14. Doge, J. T., Miltchei, C., & Hanham, D. J. (1961). The preparation and chemical characteristics of haemoglobin free ghosts on human erythrocytes. Arch. Biophys., 100, 119-126.
15. Dubois, B., Mayo, W., Agid, Y., Le Moal, M., & Simon, H. (1985). Profound disturbances of spontaneous and learned behaviours following lesions of the nucleus basalis magnocellularis in the rat. Brain Research, 338, 249-258.
16. Ellman, G. L., Courtney, K. D., Andres, V. Jr., & Fetherstone, R. M. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol., 7, 88-96.
17. Erlich, S. S., & Apuzzo, M. J. (1985). The pineal gland: Anatomy, physiology, and clinical significance. Journal of Neurosurgery, 63, 321-341.
18. Flicker, C., Dean, R. L., Watkins, D. L., Fisher, S. K., & Bartus, R. T. (1983). Behavioural and neurochemical effects following neurotoxic lesions of a major cholinergic input to the cerebral cortex in the rat. Pharmacology Biochemistry and Behavior, 18, 973-981.
19. Garton, M. J., Keir, G., Vijaya-Lakshami, M., & Tompson, J. (1991). Age-related changes in cerebrospinal fluid protein concentrations. Journal of Neurosurgical Science, 104, 74-80.
20. Gartzke, J., & Lange, K. (2002). Cellular target of weak magnetic fields: Ionic conduction along filaments of microvilli. Am. J. Physiol. Cell. Physiol., 283(5), C1333-1346.
21. Haspel, P., Linjen, R., & Amergy, A. (1986). Erythrocyte cations and Na,K-ATPase pump activity in athletes and sedentary subjects. Eur. J. Appl. Physiol. Occup. Physiol., 55(1), 249.
22. Hepler, D. J., Wenk, G. L., Gribbs, B. L., Olton, D. S., & Coyle, J. T. (1985). Memory impairments following basal forebrain lesions. Brain Research, 346, 8-14.
23. Hikmet, K., Perntgur, O., & Baria, O. (2002). Comparison of activities of Na,K-ATPase in brains of rats. Gerontology, 48, 279-281.
24. Jovanova-Nesic, K., & Vujic, D. (1988). Magnetic brain stimulation and humoral immune response in the rat with lesioned anterior hypothalamus. Yugoslav Physiologica et Pharmacologica Acta, Proceedings of the 14th Congress Yugoslav Physiological Society, Belgrade, Sept. 20-24,, 163-165.
25. Jovanova-Nesic, K., & Skokljev, A. (1990). Magnetic brain stimulation and immune response in the rat with lesioned brain structure. Acupuncture & ElectroTherapeutic Res. Int. J., 15, 27-35.
26. Kirkcaldie, M. T., Pridmore, S. A., & Pascual, L. A. (1997). Transcranial magnetic stimulation as therapy for depression and other disorders. Aust. NZJ Psychiatry, 31(2), 264-272.
27. Krause, D. N., & Dubocovich, M. L. (1990). Regulatory sites in the melatonin system of mammals. Trends Neurosci., 13, 464-470.
28. Kvitnickaya-Ruzhova, T. Y., & Shapenko, A. L. (1992). A comparative ultracythochemical and biochemical study of the choroids plexus ATPase in the aging brain. Tsitologya, 34, 81-87.
29. Liepert, J., Bar, K. J., Meske, U., & Weiller, C. (2001). Motor cortex disinhibition in Alzheimer's disease. Clin. Neurophysiol., 112(8), 1436-1441.
30. 2+ -ATPase and some soluble enzymes related to energy metabolism in brains of patients with Alzheimer's disease. Neurosci. Lett., 112, 338-342.
31. Lowry, O. H., Rosenbrough, N. J., Farr, A. K., & Randall, R. J. (1951). Protein measurement with the folic phenol reagent. J. Biol. Chem., 193, 265-275.
32. Mattson, M. P. (1998). Modification of ion homeostasis by lipid peroxidation: Roles in neuronal degeneration and adaptive plasticity. TINS, 21, 53-57.
33. Mesulam, M. M., Geula, C., & Moran, M. A. (1987). Anatomy of cholinesterase inhibition in Alzheimer's Disease: Effect of physostigmine and tetrahydroaminoacridine on plaques and tangles. Annals of Neurology, 45, 345-349.
34. Michaelis, M. L., Johe, K., & Kitos, T. E. (1984). Age-dependent alterations in synaptic membrane systems for Ca2+ regulation. Mechanisms of Aging and Development, 25, 215-225.
35. Miyamoto, M., Shintani, M., Nagaoka, A., & Nagawa, Y. (1985). Lesioning of the rat basal forebrain leads to memory impairments in passive and active avoidance tasks. Brain Research, 328, 97-104.
36. Paxinos, G., & Watson, C. (1982). The rat brain in streotaxic coordinates. Sydney: Academic, Press.
37. Pellerin, L., & Nouvelot, A. (1999). Focal cerebral ischemia induces a decrease in activity and a shift in ouabain affinity of Na,K-ATPase isoforms without modification in mRNA and protein expression. Brain Res., 819, 132-142.
38. Pennisi, G. (2001). Transcranial magnetic stimulation in Alzheimer's disease: Motor cortex excitability and cognitive severity. Neuroscei Lett., 314(1-2), 57-60.
39. Pepin, J. L., Bogacz, D., & Delwaide, P. J. (1999). Motor cortex inhibition is not impaired in patients with Alzheimer's disease: Evidence from paired transcranial magnetic stimulation. J. Neurol. Science, 170(2), 119-123.
40. Perretti, A., Grossi, D., Fragassi, N., Lanzillo, B., Nolanom, M., & Santoro, L. (1996). Evaluation of the motor cortex by magnetic stimulation in patients with Alzheimer's disease. J. Neurol. Sci., 135(1), 31-7.
41. Perry, E. K. (1986). The cholinergic hypothesis - ten years on. British Medical Bulletin, 42, 63-69.
42. Popovic, M., Jovanova-Nesic, K., Bokonjic, D., Dobric, S., Popovic, N., & Rosic, N. (1995). Effect of verapamil on spontaneous motor activity and two-way avoidance learning in nucleus basalis-lesioned rats. Europ. J. Neuroscience (suppl.), 8, 171.
43. Popovic, M., Jovanova-Nesic, K., Popovic, N., Bokonjic, D., Rosic, N., & Rakic, L. (1996). Behavioural and adaptive status in an experimental model of Alzheimer's disease in rats. International Journal of Neurosicence, 86, 281-299.
44. Popovic, M., Popovic, N., Jovanova-Nesic, K., Bokonjic, D., Dobric, S., & Rosic, N. (1997a). Open field behaviour in nucleus basalis magnocellularis-lesioned rats treated with physostigmine and verapamil. International Journal of Neurosicenec, 91(3-4), 181-188.
45. Popovic, M., Popovic, N., Jovanova-Nesic, K., Bokonjic, D., Dobric, S., Kostic, V., & Rosic, N. (1997b). Effect of physostigmine and verapamil on active avoidance in an experimental model of Alzheimer's disease. International Journal of Neuroscience, 90, 87-97.
46. Roth, M. (1986). The association of clinical and neurological findings and its bearing on the classification and etiology of Alzheimer's disease. British Medical Bulletin, 42, 42-50.
47. Rudolph, K., Witz-Justice, A., Krauchi, K., & Feer, H. (1988). Static magnetic fields decrease nocturnal pineal cAMP in the rat. Brain Research, 446, 159-160.
48. Sandyk, R. (1987). Regulatory sites in the melatonin system of mammals. Trends Neurosci., 13, 464-470.
49. Sandyk, R. (1990). Pineal melatonin functions and the depression of Parkinson's disease: A hypothesis. International Journal of Neuroscience, 51, 73-77.
50. Sandyk, R. (1991). The relationship of pineal calcification and melatonin secretion to the pathophysiology of tardive dyskinesia and Tourette's syndrome. International Journal of Neuroscience, 58, 215-247.
51. Sandyk, R., & Iacono, R. P. (1988). The relationship of the reticular system to the primary patho etiology of Parkinson's disease. International Journal of Neuroscience, 42, 297-300.
52. Sandyk, R., & Fisher, H. (1989). Increased incidence of neuroleptic-induced movement disorders in pinealectomized rats. International Journal of Neuroscience, 48, 303-308.
53. Sandyk, R., Anninos, P. A., & Tsagas, N. (1991). Magnetic fields and seasonality of affective illness: Implication for therapy. International Journal of Neuroscience, 58, 261-267.
54. Sandyk, R., & Derpapas, K. (1993). Further observation on unique efficacy of picotesla magnetic fields in Parkinson's disease. International Journal of Neuroscience, 69, 167-183.
55. Sandyk, R., & Iacono, R. P. (1993a). Rapid improvement of visuoperceptive functions by picotesla range magnetic fields in Parkinson's disease. International Journal of Neuroscience, 70, 233-254.
56. Sandyk, R., & Iacono, R. P. (1993b). Reversal of visual neglect in Parkinson's disease by treatment with picotesla magnetic fields. International Journal of Neuroscience, 73, 93-107.
57. Sandyk, R. (1994). Alzheimer's disease: Improvement of visual memory and visuoconstructive performance by treatment with picotesla range magnetic fields. International Journal of Neuroscience, 76, 185-225.
58. Sandyk, R., & Iacono, R. P. (1994). Reversal of micrographia in Parkinson's disease by application of picotesla range magnetic fields. International Journal of Neuroscience, 77, 77-84.
59. Sandyk, R. (1995). Improvement in short-term visual memory by weak electromagnetic fields in Parkinson's disease. International Journal of Neuroscience, 81, 67-82.
60. Saper, C., German, D., & White, C. (1985). Neuronal pathology in nucleus basalis and associated cell groups in senile dementia of the Alzheimer type: Possible role in cell loss. Neurology, 35, 1089-1095.
61. Savalainen, K. M., Loikkanen, J., Erikaina, S., & Naarala, J. (1998). Interactions of excitatory neurotransmitters and xenobiotics in excitatory and oxidative stress. Toxicol Letters, 28(102-103), 363-367.
62. Siegel, G. J., Chauhan, N. B., & Lee, J. M. (1998). Age-related Na,K,-ATPase mRNA expression and Alzheimer's disease. In: Progress in Alzheimer's and Parkinson's Diseases, edited by Fisher, A., Hanin, I., and Yoshida, M. New York: Plenum Press, 1998, 113-119.
63. Smith, G. (1988). Animal model of Alzheimer's disease: Experimental cholinergic denervation. Brain Research Review, 13, 103-118.
64. Sruys-Ponsar, C., Guillard, O., & van den Bosch de Aguilar, P. (2000). Effects of aluminium expose on glutamate metabolism: A possible explanation for its toxicity. Exp. Neurol., 163(1), 157-164.
65. Viani, P., Cervato, G., Fiorilli, A., & Cestaro, B. (1991). Age-related differences in synaptosomal peroxidase damage and membrane proteins. J. Neurochem., 56, 253-258.
66. Wahal, C., & Wincour, P. D. (1992). The relationship of chemical modification of membrane proteins and plasma lipoproteins to reduced membrane fluidity of erythrocytes from diabetic subjects. Eur. J. Clin. Biochem., 30, 513-519.
67. Wever, R. (1968). Einflus Schwacher Electro-magnetisher Felder and dieCircadiane Periodik des. Menschen Naturwissenschaften, 55, 29-32.
68. + -ATPase. Biophysical Journal, 67(245), 1247-1251.
69. Zubenko, G. S., Moosy, J., Hanin, I., Martinez, J., Rao, G. R., & Koop, U. (1988). Bilateral symmetry of cholinergic deficits in Alzheimer's Disease. Archives of Neurology, 54, 255-259.